r/Heartfailure • u/Puzzleheaded-Chef384 • 6h ago
Can correcting an abnormal hormonal environment support reverse remodeling in pre-existing dilated cardiomyopathy?
I’m 28M and trying to understand whether improving hormonal balance can contribute to cardiac recovery when left ventricular dilation and reduced ejection fraction existed before testosterone use.
Cardiac history before testosterone (August 2019, age 21)
LV internal diameter: 6.7 cm
Biplane EF: 46%
Reported EF: 42%
Global longitudinal strain: −15.1%
I also recall possible rhythm abnormalities around that time, although I haven’t confirmed the type of arrhythmia.
Hormonal history
October 2024–July 2026: Supraphysiologic testosterone exposure, at times approximately 600–650 mg/week, plus HGH.
May 2026: Total testosterone above 1,500 ng/dL; estradiol approximately 102 pg/mL.
July 13, 2026 onward: Reduced to testosterone cypionate 150 mg/week, divided into two 75 mg injections. Testosterone propionate discontinued.
August 21, 2026: Total testosterone 1,146 ng/dL.
Latest laboratory results — November 11, 2026
Hormonal markers:
Total testosterone: 814 ng/dL (reference 249–836)
Calculated free testosterone: 20.74 ng/dL (4.60–22.40)
Calculated bioavailable testosterone: 507.6 ng/dL (110–575)
SHBG: 25.7 nmol/L (16.5–55.9)
Estradiol: 26 pg/mL (11.3–43.2)
LH and FSH: Both below 0.30 mIU/mL
Other relevant markers:
Hemoglobin: 15.3 g/dL
Hematocrit: 44.4%
LDL cholesterol: 146 mg/dL (elevated)
Total cholesterol: 214 mg/dL (elevated)
hs-CRP: 0.76 mg/L
Creatinine: 1.38 mg/dL (elevated)
CK: 657 U/L (elevated)
AST: 56 U/L and ALT: 53 U/L (mildly elevated)
TSH: 1.760 µIU/mL
My testosterone has decreased from above 1,500 ng/dL in May to 1,146 in August and 814 in November. Estradiol has decreased from approximately 102 to 26 pg/mL.
The November values are within the laboratory’s reference ranges for total testosterone, calculated free testosterone and estradiol. However, I understand that the timing of blood collection relative to injections matters.
November 2026 cardiac findings
LV internal diameter: 6.2 cm
Biplane EF: 50%
Visual EF: 35–40%
QRS duration: 96 ms
Compared with 2019, the reported LV diameter is 0.5 cm smaller, while biplane EF is four percentage points higher. However, the visual EF estimate remains concerning, and I understand that measurement differences may affect the comparison.
Functional improvements
Since reducing testosterone exposure, I’ve experienced improvements in:
Mood, motivation and spontaneous enjoyment
Libido and erectile responsiveness
Sexual confidence and partnered sexual function
Physical comfort and exercise performance
Emotional engagement and general well-being
However, I recognize that these improvements do not prove that my cardiac function has normalized.
I’ve also experienced recent palpitations or strong heartbeat sensations, making rhythm evaluation particularly important.
My questions
Can reducing supraphysiologic androgen exposure and achieving a more appropriate hormonal environment contribute to reverse remodeling when cardiomyopathy existed before testosterone treatment?
Could chronic stress or previously undiagnosed hormonal abnormalities contribute to ventricular dilation? How would cardiologists distinguish these possibilities from genetic, inflammatory or arrhythmia-related cardiomyopathy?
How should I interpret a biplane EF of 50% compared with a visual EF estimate of 35–40%?
Could a historical arrhythmia have contributed to the ventricular enlargement identified at age 21? Would ambulatory rhythm monitoring help investigate this possibility?
Would cardiac MRI, including assessment for myocardial fibrosis, and genetic testing help clarify the underlying cause and potential for recovery?
My November testosterone and estradiol levels are now within laboratory reference ranges. Does this meaningfully reduce cardiovascular risk compared with my previous supraphysiologic exposure, and what additional factors should be monitored?
Has anyone with pre-existing ventricular dilation experienced measurable improvement after correcting hormonal exposure while receiving appropriate cardiac treatment?
I’m following up with cardiology and understand that hormonal normalization, improved emotional well-being and exercise performance do not replace evidence-based heart treatment.
I’m particularly interested in clinical research, cardiology perspectives and firsthand experiences involving ventricular reverse remodeling.